Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-07-29
2000-02-15
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540455, 540457, 540454, 549266, 549270, A61K 31395, A61K 3133, C07D26700
Patent
active
060253509
ABSTRACT:
This invention relates to compounds of the formula ##STR1## and to pharmaceutically acceptable salts thereof. The compounds of formula 1 are potent antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial and protozoal infections by administering the compounds of formula 1.
REFERENCES:
patent: 4740502 (1988-04-01), Hannick et al.
patent: 5288709 (1994-02-01), Freiberg et al.
Fernandes et al., "New Macrolides Active Against Streptococcus pyogenes With Inducible Or Constitutive Type Of Macrolide-Lincosamide-Streptogramin B Resistance," Antimicrobial Agents and Chemotherapy, 33(1), pp. 78-81 (1989).
Biedrzycki et al., "Erythromycin Derivatives. Part VI. Carbamates of Cyclic 11,12-Carbonate of Erythromycin A," Polish J. Chemistry, 52, pp. 315-319 (1978).
Masamune Hiroko
Su Wei-guo
Yang Bingwei V.
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
Richter Johann
Solola Taofiq A.
LandOfFree
C-4" substituted macrolide antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C-4" substituted macrolide antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-4" substituted macrolide antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1906068